Bavarian Nordic A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BVNRY Over the counter 2836 www.bavarian-nordic.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S - Apr 21st, 2026 12:39 pm
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - Apr 20th, 2026 5:28 am
Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine - Apr 15th, 2026 11:30 pm
Does Bavarian Nordic (CPSE:BAVA) Offer Value After A 37% One Year Share Price Gain - Apr 4th, 2026 6:19 pm
A Look At Bavarian Nordic (CPSE:BAVA) Valuation After Recent Share Price Momentum - Apr 4th, 2026 8:07 am
Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years - Mar 27th, 2026 1:00 am
Bavarian Nordic A/S – Notice Convening Annual General Meeting - Mar 24th, 2026 5:30 am
Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. - Mar 17th, 2026 10:49 am
Is Bavarian Nordic (CPSE:BAVA) Pricing Reflect Its Vaccine Role And DCF Earnings Signals? - Mar 15th, 2026 4:06 am
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - Mar 12th, 2026 1:30 pm
Bavarian Nordic AS (BVNKF) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ... - Mar 12th, 2026 1:02 pm
Bavarian Nordic and SII sign agreement for chikungunya vaccine production - Mar 12th, 2026 6:21 am
Bavarian Nordic Launches Next Tranche of Share Buy-Back Program - Mar 12th, 2026 12:51 am
Bavarian Nordic Publishes Annual Report 2025 - Mar 12th, 2026 12:39 am
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement - Mar 11th, 2026 1:30 am
Assessing Bavarian Nordic (CPSE:BAVA) Valuation After Recent Share Price Weakness - Mar 6th, 2026 5:22 pm
Biopharma’s recent string of CEO splits - Mar 6th, 2026 1:00 am
Bavarian Nordic CEO to Step Down After $3 Billion Bid Fails - Mar 2nd, 2026 1:25 pm
Paul Chaplin Steps Down as CEO of Bavarian Nordic - Mar 1st, 2026 11:42 pm
Monkeypox Market Competitive Landscape 2026: Comprehensive Insights About 8+ Companies and 10+ Drugs - Feb 18th, 2026 8:22 am